Becton, Dickinson and Co. (NYSE:BDX) presented their roadmap for the future on their recent analyst day briefing. The presentation laid out ambitious plans that management has set out for the company through to 2019, including targeting top line expansion and double-digit bottom line expansion to be driven by margin improvements. The management has also set out to increase dividends through to 2019, through roughly $11 billion in operating cash flow (OCF) generation.
QIAGEN and CosmosID, a leading genomic big data company, today announced the launch of a metagenomics analysis plugin for the QIAGEN Microbial Genomics Pro Suite and CLC Genomics Workbench. The launch of the Cosmos ID plugin expands QIAGEN’s industry leading platform for NGS bioinformatics and strengthens its role as a provider of Sample to Insight metagenomics solutions.
Seeking to deliver the “final nail in the coffin for HIV,” NIH scientists have kicked off a large clinical trial of a vaccine regimen this week in South Africa.
Under a collaboration that includes GlaxoSmithKline and Sanofi Pasteur, the National Institute of Allergy and Infectious Diseases started a phase 2b/3 trial of a new vaccine regimen in 5,400 sexually active men and women aged 18 to 35 who don’t have the infection. They’ll receive five injections over a year.
Scientific efforts to find cures for cancer will be severely hampered if the scientific community does not change the ways in which patient data is collected, shared, and analyzed. The development of targeted therapies and immunotherapies — the two biggest hopes for cancer cures — depend on the existence of large data sets comprising patients’ genetic and clinical information. Today, that data is fragmented and guarded in silos. Indeed, the well-kept secret in the cancer space is that progress in finding cures is being impeded as much by the lack of sharing by the players in the precision medicine ecosystem as it is by the stubbornness of the underlying science.
A $65 million building was dedicated Monday afternoon at the East Baltimore Development Inc. project that will include a business incubator, research space and a Starbucks job training site.
The University of Virginia Health System has named its first-ever Chief Innovation Officer, a position that’s expected to bridge the gap between research and treatment.
UVA is home to revolutionizing research and technology but newly-hired CIO Jeff Keller will facilitate in putting the research to use.
House and Senate leaders announced late Friday night that they had finally hammered out a deal on landmark legislation designed to speed federal approval of new drugs and devices and boost funding of medical research.
But what Republican lawmakers call the “final” version of the 21st Century Cures Act is actually still in negotiation with Senate Democrats, a senior Democratic aide told STAT on Sunday.
The 2017 FLC Awards is now open for nominations. One of the most coveted honors in the technology transfer field, the FLC Awards have been presented to over 200 federal laboratories since their inception in 1984. Many of our winning technology transfer efforts have gone on to become products and devices that are indispensable in our daily lives, including:
House and Senate health committee leaders have released the final “21st Century Cures” bill and announced that the House of Representatives will vote Wednesday on a $6.3 Billion landmark medical innovation package that will accelerate the discovery, development, and delivery of new cures and treatments and provide new funding for the National Institutes of Health and Food and Drug Administration. The leaders said the House would also vote Wednesday to include in the Cures bill legislation that updates major mental health programs for the first time in a decade. The new funding includes $1 billion in state grants to fight opioid abuse.
The Institute of Human Virology at the University of Maryland School of Medicine will receive $138 million in federal funds that will support the work of the newly created Center for International Health, Education and Biosecurity to build programs in Africa to combat HIV/AIDS.
